BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept.
Ann Rheum Dis
; 82(6): 881-883, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-36657954
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
Immunoglobulin G4-Related Disease
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Ann Rheum Dis
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: